Regenerative Medicine Utrecht, our partners in the m2M framework, have recently published an article outlining their work on the project, providing valuable insights into their ongoing efforts.
“A subsidy has also been awarded to the Biofabrication group of professor Jos Malda. Their micro2MACRO project focuses on directing the development of cells after printing. In many cases, printed cells are not yet fully functional and need to grow and develop. The solution for this could lie in printing detailed, degradable structures that help the cells complete this development”, you can read in the statement that was shared.
Exciting, right? This innovative work could be the key for a future of personalised regenerative therapies! Imagine printed cells that not only grow but thrive, guided by these smart, degradable structures. The future of medicine is being printed today! 🧬
Review the complete article to gain a deeper insight into the various innovative projects our partner is currently undertaking.
